Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 313

1.
2.

Stereotactic radiotherapy concurrent to immune or targeted therapy for oligometastatic NSCLC: Clinical scenarios affecting survival.

Kroeze SGC, Fritz C, Kaul D, Blanck O, Kahl K, Roeder F, Siva S, Verhoeff JJC, Grosu AL, Schymalla MM, Glatzer M, Szuecs M, Geier M, Skazikis G, Sackerer I, Lohaus F, Eckert F, Guckenberger M.

Ann Oncol. 2019 Apr;30 Suppl 2:ii63. doi: 10.1093/annonc/mdz063.071. No abstract available.

3.

First-line pembrolizumab for non-small cell lung cancer patients with PD-L1 ≥50% in a multicenter real-life cohort: The PEMBREIZH study.

Amrane K, Geier M, Corre R, Léna H, Léveiller G, Gadby F, Lamy R, Bizec JL, Goarant E, Robinet G, Gouva S, Quere G, Abgral R, Schick U, Bernier C, Chouaid C, Descourt R.

Cancer Med. 2020 Feb 5. doi: 10.1002/cam4.2806. [Epub ahead of print]

4.

Enzymes revolutionize the bioproduction of value-added compounds: From enzyme discovery to special applications.

Wiltschi B, Cernava T, Dennig A, Galindo Casas M, Geier M, Gruber S, Haberbauer M, Heidinger P, Herrero Acero E, Kratzer R, Luley-Goedl C, Müller CA, Pitzer J, Ribitsch D, Sauer M, Schmölzer K, Schnitzhofer W, Sensen CW, Soh J, Steiner K, Winkler CK, Winkler M, Wriessnegger T.

Biotechnol Adv. 2020 May - Jun;40:107520. doi: 10.1016/j.biotechadv.2020.107520. Epub 2020 Jan 23. Review.

5.

Examining the evidence that ethylmercury crosses the blood-brain barrier.

Kern JK, Geier DA, Homme KG, Geier MR.

Environ Toxicol Pharmacol. 2020 Feb;74:103312. doi: 10.1016/j.etap.2019.103312. Epub 2019 Dec 9. Review.

PMID:
31841767
6.

Management and outcomes of non-small cell lung cancer patients with rapid progression under second-or-more-line immune checkpoint inhibitors: ERORECI study (GFPC 2016-04).

Vergnenegre A, Geier M, Guisier F, Lamy R, Comet B, Le Garff G, Do P, Janicot H, Morel H, Decroisette C, Andre M, Falchero L, Paleiron N, Monnet I; GFPC Team.

Cancer Med. 2020 Jan;9(2):432-439. doi: 10.1002/cam4.2716. Epub 2019 Nov 20.

7.

Down syndrome as a genetic model to evaluate the role of oxidative stress and transsulfuration abnormalities in autism spectrum disorder: A 10-year longitudinal cohort study.

Geier DA, Kern JK, Geier MR.

Dev Neurobiol. 2019 Sep;79(9-10):857-867. doi: 10.1002/dneu.22726. Epub 2019 Dec 4.

PMID:
31742925
8.

A Cross-Sectional Study of Blood Ethylmercury Levels and Cognitive Decline Among Older Adults and the Elderly in the United States.

Geier DA, Kern JK, Homme KG, Geier MR.

J Alzheimers Dis. 2019;72(3):901-910. doi: 10.3233/JAD-190894.

9.

Comparison of BG-Lure and BG-Sweetscents attractants for field sampling of phlebotomine sand flies.

Ortiz DGS, Borges DA, Trinca LA, Galati EAB, Gordon U, Geier M, Pinto MC.

Acta Trop. 2020 Feb;202:105224. doi: 10.1016/j.actatropica.2019.105224. Epub 2019 Oct 17.

PMID:
31629825
10.
11.

Prebiotics Fructo-, Galacto-, and Mannan-Oligosaccharide Do Not Protect against 5-Fluorouracil-Induced Intestinal Mucositis in Rats.

Yazbeck R, Lindsay RJ, Geier MS, Butler RN, Howarth GS.

J Nutr. 2019 Dec 1;149(12):2164-2173. doi: 10.1093/jn/nxz192.

PMID:
31504729
12.

Field Trials to Evaluate the Effectiveness of the Biogents®-Sweetscent Lure in Combination with Several Commercial Mosquito Traps and to Assess the Effectiveness of the Biogents-Mosquitaire Trap with and Without Carbon Dioxide.

Degener CM, Geier M, Kline D, Urban J, Willis S, Ramirez K, Cloherty ER, Gordon SW.

J Am Mosq Control Assoc. 2019 Mar;35(1):32-39. doi: 10.2987/18-6790.1.

PMID:
31442187
13.

Intra-cranial efficacy of brigatinib in an ALK-positive non-small cell lung cancer patient presenting leptomeningeal carcinomatosis.

Gaye E, Geier M, Bore P, Guilloïque M, Lucia F, Quéré G, Gouva S, Robinet G, Descourt R.

Lung Cancer. 2019 Jul;133:1-3. doi: 10.1016/j.lungcan.2019.04.013. Epub 2019 Apr 20.

PMID:
31200813
14.

Definitive, intensity modulated tomotherapy with a simultaneous integrated boost for prostate cancer patients - Long term data on toxicity and biochemical control.

Schiller K, Geier M, Duma MN, Nieder C, Molls M, Combs SE, Geinitz H.

Rep Pract Oncol Radiother. 2019 Jul-Aug;24(4):315-321. doi: 10.1016/j.rpor.2019.05.004. Epub 2019 May 30.

PMID:
31193851
15.

Coupling Genome-wide Transcriptomics and Developmental Toxicity Profiles in Zebrafish to Characterize Polycyclic Aromatic Hydrocarbon (PAH) Hazard.

Shankar P, Geier MC, Truong L, McClure RS, Pande P, Waters KM, Tanguay RL.

Int J Mol Sci. 2019 May 25;20(10). pii: E2570. doi: 10.3390/ijms20102570.

16.

A critique that misses the mark.

Geier DA, Kern JK, Homme KG, Geier MR.

Int J Hyg Environ Health. 2019 Mar;222(2):309-310. doi: 10.1016/j.ijheh.2018.11.006. No abstract available.

PMID:
30850066
17.

A cross-sectional study of the relationship between reported human papillomavirus vaccine exposure and the incidence of reported asthma in the United States.

Geier DA, Kern JK, Geier MR.

SAGE Open Med. 2019 Jan 8;7:2050312118822650. doi: 10.1177/2050312118822650. eCollection 2019.

18.

Premature Puberty and Thimerosal-Containing Hepatitis B Vaccination: A Case-Control Study in the Vaccine Safety Datalink.

Geier DA, Kern JK, Geier MR.

Toxics. 2018 Nov 15;6(4). pii: E67. doi: 10.3390/toxics6040067.

19.

Publisher Correction: Engineered bidirectional promoters enable rapid multi-gene co-expression optimization.

Vogl T, Kickenweiz T, Pitzer J, Sturmberger L, Weninger A, Biggs BW, Köhler EM, Baumschlager A, Fischer JE, Hyden P, Wagner M, Baumann M, Borth N, Geier M, Ajikumar PK, Glieder A.

Nat Commun. 2018 Oct 29;9(1):4566. doi: 10.1038/s41467-018-07112-1.

20.

Host Decoy Trap (HDT) with cattle odour is highly effective for collection of exophagic malaria vectors.

Abong'o B, Yu X, Donnelly MJ, Geier M, Gibson G, Gimnig J, Ter Kuile F, Lobo NF, Ochomo E, Munga S, Ombok M, Samuels A, Torr SJ, Hawkes FM.

Parasit Vectors. 2018 Oct 15;11(1):533. doi: 10.1186/s13071-018-3099-7.

21.

Engineered bidirectional promoters enable rapid multi-gene co-expression optimization.

Vogl T, Kickenweiz T, Pitzer J, Sturmberger L, Weninger A, Biggs BW, Köhler EM, Baumschlager A, Fischer JE, Hyden P, Wagner M, Baumann M, Borth N, Geier M, Ajikumar PK, Glieder A.

Nat Commun. 2018 Sep 4;9(1):3589. doi: 10.1038/s41467-018-05915-w. Erratum in: Nat Commun. 2018 Oct 29;9(1):4566.

22.

Acceptability of Naloxone Dispensing Among Pharmacists.

Do V, Behar E, Turner C, Geier M, Coffin P.

J Pharm Pract. 2018 Sep 4:897190018798465. doi: 10.1177/0897190018798465. [Epub ahead of print]

23.

Feasibility of radiotherapy in nonagenarian patients: a retrospective study.

Kocik L, Geinitz H, Track C, Geier M, Nieder C.

Strahlenther Onkol. 2019 Jan;195(1):62-68. doi: 10.1007/s00066-018-1355-6. Epub 2018 Aug 30.

PMID:
30167713
24.

Evaluation of the Impact of a Multimodel Intervention on Prescribing Patterns of Sedative-Hypnotics in a Behavioral Health System.

Avdagic K, Geier M, Coralic Z, Finley P.

Prim Care Companion CNS Disord. 2018 May 31;20(3). pii: 18m02269. doi: 10.4088/PCC.18m02269.

25.

A longitudinal ecological study of seasonal influenza deaths in relation to climate conditions in the United States from 1999 through 2011.

Geier DA, Kern JK, Geier MR.

Infect Ecol Epidemiol. 2018 May 16;8(1):1474708. doi: 10.1080/20008686.2018.1474708. eCollection 2018.

26.

Cerebral hypoperfusion in autism spectrum disorder.

Bjørklund G, Kern JK, Urbina MA, Saad K, El-Houfey AA, Geier DA, Chirumbolo S, Geier MR, Mehta JA, Aaseth J.

Acta Neurobiol Exp (Wars). 2018;78(1):21-29. Review.

27.

Systematic developmental neurotoxicity assessment of a representative PAH Superfund mixture using zebrafish.

Geier MC, James Minick D, Truong L, Tilton S, Pande P, Anderson KA, Teeguardan J, Tanguay RL.

Toxicol Appl Pharmacol. 2018 Sep 1;354:115-125. doi: 10.1016/j.taap.2018.03.029. Epub 2018 Apr 6.

28.

Human Enzymes for Organic Synthesis.

Winkler M, Geier M, Hanlon SP, Nidetzky B, Glieder A.

Angew Chem Int Ed Engl. 2018 Oct 8;57(41):13406-13423. doi: 10.1002/anie.201800678. Epub 2018 Sep 11. Review.

29.

The risk of neurodevelopmental disorders following Thimerosal-containing Hib vaccine in comparison to Thimerosal-free Hib vaccine administered from 1995 to 1999 in the United States.

Geier DA, Kern JK, Homme KG, Geier MR.

Int J Hyg Environ Health. 2018 May;221(4):677-683. doi: 10.1016/j.ijheh.2018.03.004. Epub 2018 Mar 14.

PMID:
29573974
30.

Mercury-associated diagnoses among children diagnosed with pervasive development disorders.

Geier DA, Kern JK, Sykes LK, Geier MR.

Metab Brain Dis. 2018 Jun;33(3):949-960. doi: 10.1007/s11011-018-0211-9. Epub 2018 Mar 6.

PMID:
29512044
31.

Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients.

Hecht M, Meier F, Zimmer L, Polat B, Loquai C, Weishaupt C, Forschner A, Gutzmer R, Utikal JS, Goldinger SM, Geier M, Hassel JC, Balermpas P, Kiecker F, Rauschenberg R, Dietrich U, Clemens P, Berking C, Grabenbauer G, Schadendorf D, Grabbe S, Schuler G, Fietkau R, Distel LV, Heinzerling L.

Br J Cancer. 2018 Mar 20;118(6):785-792. doi: 10.1038/bjc.2017.489. Epub 2018 Feb 13.

32.

A cross-sectional study of the relationship between infant Thimerosal-containing hepatitis B vaccine exposure and attention-deficit/hyperactivity disorder.

Geier DA, Kern JK, Homme KG, Geier MR.

J Trace Elem Med Biol. 2018 Mar;46:1-9. doi: 10.1016/j.jtemb.2017.11.001. Epub 2017 Nov 8.

PMID:
29413097
33.

Developmental neurotoxicants and the vulnerable male brain: a systematic review of suspected neurotoxicants that disproportionally affect males.

Kern JK, Geier DA, Homme KG, King PG, Bjørklund G, Chirumbolo S, Geier MR.

Acta Neurobiol Exp (Wars). 2017;77(4):269-296. Review.

34.

A Cross-Sectional Study of the Association between Infant Hepatitis B Vaccine Exposure in Boys and the Risk of Adverse Effects as Measured by Receipt of Special Education Services.

Geier DA, Kern JK, Homme KG, Geier MR.

Int J Environ Res Public Health. 2018 Jan 12;15(1). pii: E123. doi: 10.3390/ijerph15010123.

35.

Methanol independent induction in Pichia pastoris by simple derepressed overexpression of single transcription factors.

Vogl T, Sturmberger L, Fauland PC, Hyden P, Fischer JE, Schmid C, Thallinger GG, Geier M, Glieder A.

Biotechnol Bioeng. 2018 Apr;115(4):1037-1050. doi: 10.1002/bit.26529. Epub 2018 Jan 29.

PMID:
29280481
36.

Low-threshold extended-release naltrexone for high utilizers of public services with severe alcohol use disorder: A pilot study.

Smith-Bernardin S, Rowe C, Behar E, Geier M, Washington S, Santos GM, Euren J, Martin J, Gleghorn A, Coffin PO.

J Subst Abuse Treat. 2018 Feb;85:109-115. doi: 10.1016/j.jsat.2017.11.005. Epub 2017 Nov 8.

PMID:
29150316
37.

A cross-sectional study of the relationship between blood lead levels and reported attention deficit disorder: an assessment of the economic impact on the United States.

Geier DA, Kern JK, Geier MR.

Metab Brain Dis. 2018 Feb;33(1):201-208. doi: 10.1007/s11011-017-0146-6. Epub 2017 Nov 13.

PMID:
29134344
38.

Systematic Assessment of Research on Autism Spectrum Disorder (ASD) and Mercury Reveals Conflicts of Interest and the Need for Transparency in Autism Research.

Kern JK, Geier DA, Deth RC, Sykes LK, Hooker BS, Love JM, Bjørklund G, Chaigneau CG, Haley BE, Geier MR.

Sci Eng Ethics. 2017 Dec;23(6):1691-1718. doi: 10.1007/s11948-017-9983-2. Review. Retraction in: Sci Eng Ethics. 2017 Dec;23(6):1689-1690.

39.

Comparative developmental toxicity of a comprehensive suite of polycyclic aromatic hydrocarbons.

Geier MC, Chlebowski AC, Truong L, Massey Simonich SL, Anderson KA, Tanguay RL.

Arch Toxicol. 2018 Feb;92(2):571-586. doi: 10.1007/s00204-017-2068-9. Epub 2017 Nov 1.

40.

Demographic and neonatal risk factors for childhood asthma in the USA.

Geier DA, Kern JK, Geier MR.

J Matern Fetal Neonatal Med. 2019 Mar;32(5):833-837. doi: 10.1080/14767058.2017.1393068. Epub 2017 Oct 29.

PMID:
29034748
41.

Blood Lead Levels and Learning Disabilities: A Cross-Sectional Study of the 2003-2004 National Health and Nutrition Examination Survey (NHANES).

Geier DA, Kern JK, Geier MR.

Int J Environ Res Public Health. 2017 Oct 10;14(10). pii: E1202. doi: 10.3390/ijerph14101202.

42.

Comparison of Efficiency of BG-Sentinel Traps Baited with Mice, Mouse-Litter, and CO₂ Lures for Field Sampling of Male and Female Aedes albopictus Mosquitoes.

Le Goff G, Damiens D, Ruttee AH, Payet L, Lebon C, Dehecq JS, Geier M, Gouagna LC.

Insects. 2017 Sep 1;8(3). pii: E95. doi: 10.3390/insects8030095.

43.

Towards systems metabolic engineering in Pichia pastoris.

Schwarzhans JP, Luttermann T, Geier M, Kalinowski J, Friehs K.

Biotechnol Adv. 2017 Nov 1;35(6):681-710. doi: 10.1016/j.biotechadv.2017.07.009. Epub 2017 Jul 29. Review.

PMID:
28760369
44.

Biomimetic Platinum-Promoted Polyene Polycyclizations: Influence of Alkene Substitution and Pre-cyclization Conformations.

McCulley CH, Geier MJ, Hudson BM, Gagné MR, Tantillo DJ.

J Am Chem Soc. 2017 Aug 16;139(32):11158-11164. doi: 10.1021/jacs.7b05381. Epub 2017 Aug 3.

45.

Solution-Processed Carbon Nanotube True Random Number Generator.

Gaviria Rojas WA, McMorrow JJ, Geier ML, Tang Q, Kim CH, Marks TJ, Hersam MC.

Nano Lett. 2017 Aug 9;17(8):4976-4981. doi: 10.1021/acs.nanolett.7b02118. Epub 2017 Jul 7.

PMID:
28671471
46.
47.
48.

Neonatal factors among subjects diagnosed with a pervasive developmental disorder in the US.

Geier D, Kern J, Geier M.

J Matern Fetal Neonatal Med. 2018 Jul;31(13):1709-1714. doi: 10.1080/14767058.2017.1326096. Epub 2017 May 19.

PMID:
28462601
49.
50.

Histone deacetylase inhibitors, Thimerosal, and autism spectrum disorder.

Bjørklund G, Chirumbolo S, Geier DA, Kern JK, Geier MR.

Environ Res. 2017 Jul;156:843-844. doi: 10.1016/j.envres.2017.04.007. Epub 2017 Apr 11. No abstract available.

PMID:
28410622

Supplemental Content

Support Center